ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1134 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-07-01

Study Completion Date

2018-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objectives of this study is to estimate the real-world safety profile of Eliquis in Japanese Venous Thromboembolism patients and to estimate the risk factors likely to affect the incidence of bleeding. Lastly, the secondary objective of this study is to estimate the real-world effectiveness profile of Eliquis in Japanese Venous Thromboembolism patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS

NCT02546817

Venous Thromboembolism

COMPLETED

Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico

NCT02345343

Deep Vein Thrombosis Pulmonary Embolism

COMPLETED

Eliquis Regulatory Post Marketing Surveillance (rPMS)

NCT01885585

Venous Thromboembolism

COMPLETED

Evaluation of the Effectiveness of Eliquis ® (Apixaban) Risk Minimization Tools in European Economic Area (EEA) Countries

NCT02339818

Stroke, Systemic Embolism, VTEt and VTEp

COMPLETED

Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus

NCT02982590

Left Ventricular Thrombosis

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Venous Thromboembolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Population with Exposure to ELIQUIS (APIXABAN)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who are initiating Eliquis for the treatment of VTE or prevention of recurrent VTE for the first time

Exclusion Criteria

* Prior treatment with Eliquis for nonvalvular atrial fibrillation or VTE
* Patients initiating Eliquis for the treatment of atrial fibrillation
* Off-label use of Eliquis

Eligible Sex

ALL

Accepts Healthy Volunteers

No